Valuation: genOway

Market Cap 22.22M 25.41M 20.4M 19.03M 36.07M 2.42B 36.6M 245M 95.26M 1.19B 95.39M 93.31M 4.1B P/E 2024 *
-
P/E 2025 -
Enterprise Value 28.94M 33.09M 26.57M 24.79M 46.98M 3.15B 47.67M 319M 124M 1.55B 124M 122M 5.34B EV / Sales 2024
1.28x
EV / Sales 2025 1.11x
Free-Float
59.02%
Yield 2024 *
-
Yield 2025 -
1 day+0.42%
1 week+4.33%
Current month+1.69%
1 month+0.84%
3 months-3.21%
6 months-10.74%
Current year-11.07%
1 week 2.32
Extreme 2.32
2.45
1 month 2.31
Extreme 2.31
2.5
Current year 2.18
Extreme 2.18
2.79
1 year 2.1
Extreme 2.1
3.29
3 years 2.1
Extreme 2.1
4.91
5 years 2.1
Extreme 2.1
4.91
10 years 1
Extreme 1
7.7
Manager TitleAgeSince
Chief Executive Officer - -
Chief Operating Officer - 1999-02-28
Director of Finance/CFO - 2015-09-30
Director TitleAgeSince
Director/Board Member - 1999-02-28
Chairman - -
Director/Board Member - -
Date Insider Type Main position Quantity % Market Cap.
22-01-19Buy

Chief Executive Officer

12,500 0.1376%
21-11-16Sell

Chief Executive Officer

5,000 0.0553%
21-11-12Sell

Founder

1,147 0.0127%
Change 5-day change 1-year change 3-year change Capi.($)
+0.42%+4.33%-25.85%-38.99% 25.42M
+1.70%+7.41%+3.12%+8.46% 49.92B
+0.92%+3.93%+399.71%+605.33% 40.23B
+1.89%+8.32%+26.06%-6.35% 34.55B
+2.38%+6.35%+21.25%+64.58% 33.09B
+3.96%+10.67%+11.89%+38.86% 27.51B
+2.51%+5.27% - - 17.05B
+2.58%+5.79%+73.44%+133.27% 15.92B
+0.32%+0.58%+13.67%+19.09% 13.86B
+3.30%+0.76%+90.23%+99.12% 13.52B
Average +2.00%+5.67%+68.17%+102.60% 24.57B
Weighted average by Cap. +2.07%+6.53%+90.74%+137.72%

Financials

2024 2025
Net sales 27.53M 31.48M 25.28M 23.58M 44.69M 3B 45.35M 304M 118M 1.47B 118M 116M 5.08B 28.6M 32.7M 26.26M 24.5M 46.43M 3.11B 47.11M 316M 123M 1.53B 123M 120M 5.28B
Net income 1.83M 2.09M 1.68M 1.57M 2.97M 199M 3.02M 20.2M 7.85M 97.95M 7.86M 7.69M 338M 928K 1.06M 852K 795K 1.51M 101M 1.53M 10.24M 3.98M 49.64M 3.98M 3.9M 171M
Net Debt 623K 712K 572K 534K 1.01M 67.84M 1.03M 6.87M 2.67M 33.33M 2.67M 2.62M 115M 6.72M 7.68M 6.17M 5.75M 10.91M 732M 11.07M 74.12M 28.8M 359M 28.84M 28.21M 1.24B
Logo genOway
genOway est une société de biotechnologie spécialisée dans la conception et le développement de modèles de recherche moléculaires, cellulaires et animaux à forte valeur ajoutée pour les industries biopharmaceutique, chimique, agrochimique et agroalimentaire ainsi que pour la recherche académique. genOway est une société leader sur son marché. Elle appuie son développement sur la combinaison d'une large et exclusive plateforme technologique et d'une propriété intellectuelle forte combinant brevets et licences d'exploitation. genOway a conclu de nombreux contrats commerciaux avec les leaders de l'industrie pharmaceutique (BMS, Janssen, Novartis, Pfizer, etc.), et avec les centres de recherche académiques les plus prestigieux (King's College et Université de Manchester en Angleterre, Harvard, Caltech et le National Institute of Health aux Etats-Unis, l'Institut Pasteur en France, le NGFN et l'Institut Max Planck en Allemagne, etc.).
Employees
157
Date Price Change Volume
26-07-03 €2.410 +0.42% 4,048
26-07-02 €2.400 0.00% 15,545
26-07-01 €2.400 +1.27% 3,057
26-06-30 €2.370 +0.42% 3,844
26-06-29 €2.360 +2.16% 11,740
  1. Stock Market
  2. Stocks
  3. ALGEN Stock